Nanomedicine News

RSS

New Nanoparticle Device Holds Promise for Effective Gene Therapy

Scientists have designed a nanoparticle that appears to effectively deliver genetic material into cells with minimal toxic effects. In lab experiments, the researchers have found that this device, a vector, is able to ...

7 Jul 2010

National Cancer Institute Announces Successful Test Results of Zecotek's Tunable Green Fiber Laser

National Cancer Institute Announces Successful Test Results of Zecotek's Tunable Green Fiber Laser

Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F), a developer of leading-edge photonics technologies for medical, industrial, nanotechnology and scientific markets, today announced that the National Cancer Institute, a division of the U.S. National Institute of Health (NIH) has released positive test results conducted on Zecotek's proprietary Tunable Green Fiber Laser.

From Zecotek Photonics 6 Jul 2010

Nano Silver Coating Strong Against Bacteria Yet Body Tissue-Compatible

Nano Silver Coating Strong Against Bacteria Yet Body Tissue-Compatible

Empa researchers have demonstrated how they can adjust process conditions to influence the properties of novel plasma polymer coatings containing silver nanoparticles. Tailor-made films can be generated through a one-step plasma process.

5 Jul 2010

New Nanotechnology for Enhanced Delivery of Cosmetics and Drugs Through the Skin

New Nanotechnology for Enhanced Delivery of Cosmetics and Drugs Through the Skin

A team of researchers at the University of South Australia have developed and patented new technology that allows for enhanced delivery of cosmetics and drugs through the skin.

5 Jul 2010

MagForce's Nano-Cancer Therapy Achieves European Regulatory Approval

MagForce's Nano-Cancer Therapy Achieves European Regulatory Approval

Following two decades of intensive research and development efforts, MagForce Nanotechnologies AG, a Berlin-based medical technology company founded in 1997, has received European regulatory approval for its Nano-Cancer® therapy.

From MagForce Nanotechnologies AG 1 Jul 2010

Using Nanotechnology to Bring Diseased Teeth Back to Life

Using Nanotechnology to Bring Diseased Teeth Back to Life

Scientists are reporting an advance toward the next big treatment revolution in dentistry - the era in which root canal therapy brings diseased teeth back to life, rather than leaving a "non-vital" or dead tooth in the mouth.

30 Jun 2010

University of Leeds to Develop New Cancer Drug Delivery Method with Gas Bubbles

A new way to deliver cancer drugs using gas bubbles and sound waves is to be developed at the University of Leeds. The project will enable highly toxic drugs to be delivered in small doses directly to tumours, where...

29 Jun 2010

Researchers Win Prize for Developing Technology that Could Improve Medical Imaging and Targeted Drug Delivery

Researchers from University College London have won a £25,000 prize for developing technology that could be used to improve medical imaging, the targeted delivery of drugs and much more. The 2010 Armourers and B...

29 Jun 2010

Starpharma and Monash Awarded Grant to Advance New Drug Delivery Method

Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) and the Monash Institute of Pharmaceutical Sciences (MIPS) have been awarded an Australian Research Council funding grant for the purpose of advancing a new drug deliver...

From Starpharma Holdings Ltd 28 Jun 2010

Using Nanotechnology to Deliver Toxic Platinum Atoms to Tumors

Using Nanotechnology to Deliver Toxic Platinum Atoms to Tumors

Harvard and Brigham and Women's Hospital researchers have devised a method that may allow clinicians to use higher doses of a powerful chemotherapy drug that has been limited because it is toxic not only to tumors but to patients' kidneys.

28 Jun 2010

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.